Reference
Havers FP, et al. Economic impact of implementing decennial tetanus toxoid, reduced diphtheria toxoid and acellular pertussis (Tdap) vaccination in adults in the United States. Vaccine : 31 Oct 2019. Available from: URL: https://doi.org/10.1016/j.vaccine.2019.09.104
Rights and permissions
About this article
Cite this article
DTaP booster not cost effective unless pertussis incidence high. PharmacoEcon Outcomes News 841, 17 (2019). https://doi.org/10.1007/s40274-019-6369-5
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-019-6369-5